首页> 外文期刊>Hormone and Metabolic Research >Long-Term Variations of Antithyroperoxidase Antibodies and its Clinical Significance
【24h】

Long-Term Variations of Antithyroperoxidase Antibodies and its Clinical Significance

机译:邻苯甲酸氧化酶抗体的长期变化及其临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

Various cut-offs have been proposed for thyroid peroxidase antibodies (TPOAb) positivity. Considering that the long-term trend of TPOAb levels and its positivity incidence is not clearly understood, we conducted the current study to determine the longitudinal variations of TPOAb in a population-based cohort study. We followed 5783 individuals of Tehran Thyroid cohort Study (TTS) for 10 years (4 phases). After exclusions, data of 3493 euthyroid participants remained for analyses. The baseline prevalence rates of TPOAb positivity were 19.8, 17, and 11.4% and the annual incidence rates (95% CI) of TPOAb positivity were 8.53 (8.29-8.77), 7.59 (7.37-7.80) and 6.79 (6.60-6.98) per 1000 persons for the 3 proposed cut-offs of 14.77, 18.38, and 40U/l; respectively. Although a slightly increasing trend was observed for TPOAb levels (p=0.001) and its conventional positivity (TPOAb>40U/l), the recently proposed cut-offs of 14.77 and 18.38U/l showed constant TPOAb positivity over 10 years. The time trends of the TPOAb levels among younger participants were significantly different from older participants (timexage effect p=0.004), with the former having an increasing trend and the latter, a relatively decreasing trend. Although the prevalence of TPOAb positivity was significantly (p<0.001) higher among women as compared to men, the longitudinal changes of TPOAb were similar in men and women. TPOAb positivity along with TSH values between 2.5 and 5.0mU/l or free T4 values between 0.93 and 1.7ng/dl exerted a significantly increased risk of subclinical or overt hypothyroidism. In an iodine sufficient population, an increasing trend in TPOAb levels was observed in line with the increasing incidence of subclinical and overt hypothyroidism.
机译:已经提出了各种截止的甲状腺过氧化物酶抗体(TPOAB)阳性。考虑到促进TPOAB水平及其积极发病率的长期趋势未清楚地理解,我们进行了目前的研究,以确定TPOAB在基于人群的队列研究中的纵向变化。我们跟踪了5783个德黑兰甲状腺队列研究(TTS)的个人10年(4个阶段)。排除后,3493个Euthordroid参与者的数据仍为分析。 TPOAB阳性的基线流行率为19.8,17和11.4%,TPOAB阳性的年发病率(95%CI)为8.53(8.29-8.77),7.59(7.37-7.80)和6.79(6.6.6.6.6.6.98) 3个拟议的截止值为14.77,18.38和40u / l的1000人;分别。尽管对于TPOAB水平观察到略微增加的趋势(P = 0.001)及其常规的阳性(TPOAB> 40U / L),但最近提出的14.77和18.38U / L的截止值显示出10年以上的TPOAB积极性。年轻参与者TPOAB水平的时间趋势与较旧的参与者(时曲效应P = 0.004)显着不同,前者具有增加的趋势和后者,趋势相对较低。虽然与男性相比,女性的TPOAB阳性的患病率显着(p <0.001),但TPOAB的纵向变化在男性和女性中都是相似的。 TPOAB阳性与2.5和5.0Mu / L之间的TSH值或0.93和1.7NG / DL之间的T4值介于0.93和1.7NG / DL之间的潜在甲基透明度或明显甲状腺功能亢进的风险显着增加。在碘群体中,随着亚临床和明显甲状腺功能亢进的发病率的增加,观察到TPOAB水平的增加趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号